agouti-related protein



agouti-related protein

A1AA1Q2QQ2M3MM3G4GG4L5LL5A6AA6P7PP7M8MM8E9EE9G10GG10I11II11R12RR12R13RR13P14PP14D15DD15Q16QQ16A17AA17L18LL18L19LL19P20PP20E21EE21L22LL22P23PP23G24GG24L25LL25G26GG26L27LL27R28RR28A29AA29P30PP30L31LL31K32KK32K33KK33T34TT34T35TT35A36AA36E37EE37Q38QQ38A39AA39E40EE40E41EE41D42DD42L43LL43L44LL44Q45QQ45E46EE46A47AA47... and 65 more residue(s)...... and 65 more residue(s)

SMILES None
InChIKey None
Sequence AQMGLAPMEGIRRPDQALLPELPGLGLRAPLKKTTAEQAEEDLLQEAQALAEVLDLQDREPRSSRRCVRLHESCLGQQVPCCDPCATCYCRFFNAFCYCRKLGTAMNPCSRT

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Ligand site mutations MC4


No bioactivity data available.

agouti-related protein

A1AA1Q2QQ2M3MM3G4GG4L5LL5A6AA6P7PP7M8MM8E9EE9G10GG10I11II11R12RR12R13RR13P14PP14D15DD15Q16QQ16A17AA17L18LL18L19LL19P20PP20E21EE21L22LL22P23PP23G24GG24L25LL25G26GG26L27LL27R28RR28A29AA29P30PP30L31LL31K32KK32K33KK33T34TT34T35TT35A36AA36E37EE37Q38QQ38A39AA39E40EE40E41EE41D42DD42L43LL43L44LL44Q45QQ45E46EE46A47AA47... and 65 more residue(s)...... and 65 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations MC4


Compound is not listed as a drug.